India to Brazil: Temozolomide Export Trade Route
India has recorded 20 verified shipments of Temozolomide exported to Brazil, representing a combined trade value of $2.5M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $125.7K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 70% of total export value with 15 shipments worth $1.7M USD. On the buying side, M/S. SUN FARMACEUTICA DO BRAZIL LTD is the largest importer in Brazil with $980.0K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Temozolomide corridor is one of India's established pharmaceutical export routes, with 20 shipments documented worth a combined $2.5M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 70% of all export value, reflecting the consolidated nature of India's temozolomide manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $125.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with temozolomide's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 31.8%, placing it at rank #8 among India's top temozolomide export destinations globally.
On the import side, key buyers of Indian temozolomide in Brazil include M/S. SUN FARMACEUTICA DO BRAZIL LTD, SUN FARMACEUTICA DO BRASIL LTD, SUN FARMACEUTICA DO BRASIL LIMITED and 10 others. M/S. SUN FARMACEUTICA DO BRAZIL LTD is the single largest importer with 5 shipments valued at $980.0K USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ3
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#8
- Annual growth+31.8%
- Demand growth+28.3%
- Regulatory ease82/100
Top 10 Indian Temozolomide Exporters to Brazil
Showing top 10 of 5 Indian suppliers exporting Temozolomide to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $116.7K per shipment | 15 | $1.7M | 69.6% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $381.9K per shipment | 2 | $763.8K | 30.4% |
| 3 | ALLEVIARE LIFE SCIENCES PRIVATE LIMITED Avg $202 per shipment | 1 | $202 | 0.0% |
| 4 | HETERO LABS LIMITED Avg $2 per shipment | 1 | $2 | 0.0% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting temozolomide to Brazil, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED, HETERO LABS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 15 shipments worth $1.7M USD, giving it a 70% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Temozolomide Importers in Brazil
Showing top 10 of 13 known buyers in Brazil receiving Temozolomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian temozolomide in Brazil include M/S. SUN FARMACEUTICA DO BRAZIL LTD, SUN FARMACEUTICA DO BRASIL LTD, SUN FARMACEUTICA DO BRASIL LIMITED, M S SUN FARMACEUTICA DO BRAZIL LIMITED, SUN FARMACEUTICA DO BRASIL LTDA RUA, among 13 total buyers. The largest importer is M/S. SUN FARMACEUTICA DO BRAZIL LTD, accounting for $980.0K USD across 5 shipments — representing 39% of all temozolomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S. SUN FARMACEUTICA DO BRAZIL LTD | 5 | $980.0K | 39.0% |
| 2 | SUN FARMACEUTICA DO BRASIL LTD | 2 | $763.8K | 30.4% |
| 3 | SUN FARMACEUTICA DO BRASIL LIMITED | 1 | $363.9K | 14.5% |
| 4 | M S SUN FARMACEUTICA DO BRAZIL LIMITED | 1 | $123.9K | 4.9% |
| 5 | SUN FARMACEUTICA DO BRASIL LTDA RUA | 2 | $93.4K | 3.7% |
| 6 | M/S | 2 | $61.6K | 2.4% |
| 7 | SUN FARMACEUTICA DO BRAZIL LIMITEDA | 1 | $52.9K | 2.1% |
| 8 | M S SUN FARMACEUTICA DO BRAZIL LTD | 1 | $35.7K | 1.4% |
| 9 | SUN FARMACUTICA DO BRASIL LTDA | 1 | $33.3K | 1.3% |
| 10 | SUN FARMACEUTICA DO BRAZIL LTDA | 1 | $5.2K | 0.2% |
Showing top 10 of 13 Temozolomide importers in Brazil on this route.
Top 10 Temozolomide Formulations Imported by Brazil
Showing top 10 of 18 product formulations shipped on the India to Brazil Temozolomide route, ranked by trade value
Brazil imports a wide range of temozolomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TEMOZOLOMIDA 100MG CAPSULA EACH CAPSULECONTAINS TEMOZOLOMIDE EQUIVALENT 100 MGPACK:BOX 05sx01 — accounts for $396.5K USD across 1 shipments. There are 18 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TEMOZOLOMIDA 100MG CAPSULA EACH CAPSULECONTAINS TEMOZOLOMIDE EQUIVALENT 100 MGPACK:BOX 05sx01 | 1 | $396.5K | 15.8% |
| 2 | TEMOZOLOMIDA 140 MG CAPSULA EACH CAPSULECONTAINS TEMOZOLOMIDE PACK:BOX 05Sx01 | 1 | $367.3K | 14.6% |
| 3 | TEMOZOLOMIDA 140 MG CAPSULA EACH CAPSULECONTAINS TEMOZOLOMIDE PACK:BOX 05S*01 | 1 | $363.9K | 14.5% |
| 4 | TEMOZOLOMIDA 100MG CAPSULA PACK:BOX05S*01 BATCH:HAF0561A, HAF0562A EACH CAP CONTS.TEMOZOLOMIDE EQ TO 100MG | 1 | $357.7K | 14.2% |
| 5 | TEMOZOLOMIDA 100MG CAPSULA PACK:BOX05S*01 BATCH:HAG0130A, HAG0131A EACH CAP CONTS. TEMOZOLOMIDE EQ TO 100MG | 1 | $288.7K | 11.5% |
| 6 | TEMOZOLOMIDA 100MG CAPSULA PACK:BOX05S*01 BATCH:HAF0560A EACH CAP CONTS.TEMOZOLOMIDE EQ TO 100MG | 1 | $201.5K | 8.0% |
| 7 | TEMOZOLOMIDA 100MG CAPSULA PACK: BOX05S*01 BATCH: HAG0243A EACH CAPSULE CONTAINSTEMOZOLOMIDE EQ. 100MG | 1 | $128.1K | 5.1% |
| 8 | TEMOZOLOMIDA 20MG CAPSULA PACK:BOX05S*01 BATCH:HAE1605B HAE2046AEACH CAP CONTS. TEMOZOLOMIDE EQ. | 1 | $123.9K | 4.9% |
| 9 | TEMOZOLOMIDA 20 MG CAPSULA EACH CAPSULECONTAINS TEMOZOLOMIDE EQUIVALENT (PACK:BOX 05S*01) | 2 | $93.4K | 3.7% |
| 10 | HSN Code:30049049,SAPCode:1123081,TEMOZOLOMIDA 20MG CAPSULA EACH CAPSULE CONTAINS TEMOZOLOMIDE EQUIVALENT,PACK:BOX05S*01 | 2 | $61.6K | 2.4% |
Showing top 10 of 18 Temozolomide formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 3 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's temozolomide exports to Brazil are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 15 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $125.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as temozolomida 140 mg capsula each capsulecontains temozolomide pack:box 05sx01 and temozolomida 140 mg capsula each capsulecontains temozolomide pack:box 05s*01, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S. SUN FARMACEUTICA DO BRAZIL LTD is the largest importer with 5 shipments worth $980.0K USD — representing 39% of all temozolomide imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.5M
- Avg. Shipment
- $125.7K
- Suppliers
- 5
- Buyers
- 13
- Transit (Sea)
- ~22 days
- Annual Growth
- +31.8%
Related Analysis
Other Temozolomide Routes
Unlock the Full India to Brazil Temozolomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 20 shipments on this route.
Frequently Asked Questions — India to Brazil Temozolomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Temozolomide to Brazil?
The leading Indian exporters of Temozolomide to Brazil are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, ALLEVIARE LIFE SCIENCES PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 70% of total trade value on this route.
Q What is the total value of Temozolomide exports from India to Brazil?
India exports Temozolomide to Brazil worth approximately $2.5M USD across 20 recorded shipments. The average value per shipment is $125.7K USD.
Q Which ports does India use to ship Temozolomide to Brazil?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 3 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Brazil for Temozolomide?
The average transit time for Temozolomide shipments from India to Brazil is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Brazil Temozolomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.8% with demand growth tracking at 28.3%. The route is ranked #8 among India's top Temozolomide export destinations globally.
Q How many suppliers are active on the India to Brazil Temozolomide route?
There are currently 5 active Indian suppliers exporting Temozolomide to Brazil. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 70% of total shipment value.
Q Who are the main importers of Temozolomide from India in Brazil?
The leading importers of Indian Temozolomide in Brazil include M/S. SUN FARMACEUTICA DO BRAZIL LTD, SUN FARMACEUTICA DO BRASIL LTD, SUN FARMACEUTICA DO BRASIL LIMITED, M S SUN FARMACEUTICA DO BRAZIL LIMITED, SUN FARMACEUTICA DO BRASIL LTDA RUA. M/S. SUN FARMACEUTICA DO BRAZIL LTD is the largest buyer with 5 shipments worth $980.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Temozolomide.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 13 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 20 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
20 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists